Periodontal and craniofacial regeneration presents significant challenges owing to the complex tissue architecture, inadequate vascularization, and diminished stem cell populations within damaged tissues. Traditionally, autologous bone grafts or alternative bone substitute materials have been employed to address these conditions; however, these approaches are constrained by donor site morbidity, limited availability, and suboptimal regenerative efficacy. The advancement of mesenchymal stem/stromal cell (MSC) biology has accelerated the development of cell-based therapies in modern dentistry, which now focuses on biologically driven approaches to regenerate tissues. MSC-based therapies currently under investigation, both preclinically and clinically, show promise for improving tissue integration and healing processes of both soft and hard tissues, attributable to their multipotent nature, immunomodulatory properties, and paracrine signaling capabilities. Nevertheless, obstacles persist, including inconsistent standardization, limited scalability, regulatory hurdles, a paucity of controlled studies, and restricted biomaterial options. This review evaluates MSC-based treatments for periodontal and craniofacial reconstruction by discussing recent research findings and existing obstacles. This review also examines future prospects, such as advanced biofabrication methods, including 3D printing and bioprinting, which have the potential to improve personalized cell therapy for periodontal and craniofacial regeneration.
{"title":"Cell Therapy for Periodontal, Soft-Tissue, and Craniofacial Regeneration.","authors":"Kamal Mustafa, Shuntaro Yamada, Nerea Sanchez, Magdalena Mayol, Cecilie Gjerde, Mariano Sanz","doi":"10.1111/jre.70011","DOIUrl":"https://doi.org/10.1111/jre.70011","url":null,"abstract":"<p><p>Periodontal and craniofacial regeneration presents significant challenges owing to the complex tissue architecture, inadequate vascularization, and diminished stem cell populations within damaged tissues. Traditionally, autologous bone grafts or alternative bone substitute materials have been employed to address these conditions; however, these approaches are constrained by donor site morbidity, limited availability, and suboptimal regenerative efficacy. The advancement of mesenchymal stem/stromal cell (MSC) biology has accelerated the development of cell-based therapies in modern dentistry, which now focuses on biologically driven approaches to regenerate tissues. MSC-based therapies currently under investigation, both preclinically and clinically, show promise for improving tissue integration and healing processes of both soft and hard tissues, attributable to their multipotent nature, immunomodulatory properties, and paracrine signaling capabilities. Nevertheless, obstacles persist, including inconsistent standardization, limited scalability, regulatory hurdles, a paucity of controlled studies, and restricted biomaterial options. This review evaluates MSC-based treatments for periodontal and craniofacial reconstruction by discussing recent research findings and existing obstacles. This review also examines future prospects, such as advanced biofabrication methods, including 3D printing and bioprinting, which have the potential to improve personalized cell therapy for periodontal and craniofacial regeneration.</p>","PeriodicalId":16715,"journal":{"name":"Journal of periodontal research","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144567565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p>Since Prof. Branemark established the concept of osseointegration—“a direct structural and functional connection between bone and an implant”—[<span>1</span>]; implant dentistry has been revolutionized, progressing techniques and materials for rehabilitating patients who lost their teeth using dental implants, biomaterials, and implant-supported prostheses [<span>2</span>]. After long years of clinical follow-ups, the use of dental implants proved to be a reliable long-term treatment for patients with unquestionable survival rates [<span>2</span>]. In the early ages of osseointegration, a successful osseointegrated implant was considered when after a healing period of 6–8 months, the bone-anchored implant was completely stable and surrounded by healthy and non-infected tissues, able to receive prosthetic loading and exercise mechanical function lasting long years in a patient [<span>1</span>]. After more than 50 years of successful use of dental implants, the clinical factors to declare a successful osseointegrated implant have changed [<span>2-6</span>]. Oral rehabilitation using dental implants has become a treatment dependent on specialized professionals who target handling complex long-term cases combining surgical, periodontal, and prosthetic approaches, thinking beyond just implant insertion and early osseointegration. Currently, the concept of implant success and its long-term osseointegration reveals a progressive complexity involving short and long-term factors in implant dentistry. Biological, mechanical, functional, technological, genetic, prosthetic, esthetic, and health quality indicators (PROMs) can be cited as actual components to determine implant and osseointegration success [<span>2-6</span>]. Nevertheless, many of these factors may bring up miscellaneous opinions of what should be considered “implant success” or “osseointegration success” in the currently available knowledge, as well as, patients may show different feedback's about their satisfaction with implant treatments. Osseointegration success may be considered a stable implant in oral function with the absence of inflamed/contaminated surrounding tissues and peri-implant bone loss. However, nowadays, the term “implant success” has achieved priority and embraces much more than healthy surrounding tissues; esthetics, correct implant positioning, treatment durability, changes in quality of life, and patient-related outcomes are crucial in the contemporaneous definition [<span>6</span>]. The evaluation of solely peri-implant tissue status is insufficient to achieve the current clinical scientific evidence needed to report quality of care, patient satisfaction, and treatment success in implant dentistry [<span>6</span>]. These multiple factors highlight the need for optimal surgical planning and safety protocols in implantology aiming for long-term clinical durability. On the other hand, questionable treatments with dental implants and diverse clinical decisions may curren
{"title":"Redefining Success in Implant Dentistry: Beyond Mere Implant Placement","authors":"Marcel F. Kunrath, Christer Dahlin","doi":"10.1111/jre.70009","DOIUrl":"10.1111/jre.70009","url":null,"abstract":"<p>Since Prof. Branemark established the concept of osseointegration—“a direct structural and functional connection between bone and an implant”—[<span>1</span>]; implant dentistry has been revolutionized, progressing techniques and materials for rehabilitating patients who lost their teeth using dental implants, biomaterials, and implant-supported prostheses [<span>2</span>]. After long years of clinical follow-ups, the use of dental implants proved to be a reliable long-term treatment for patients with unquestionable survival rates [<span>2</span>]. In the early ages of osseointegration, a successful osseointegrated implant was considered when after a healing period of 6–8 months, the bone-anchored implant was completely stable and surrounded by healthy and non-infected tissues, able to receive prosthetic loading and exercise mechanical function lasting long years in a patient [<span>1</span>]. After more than 50 years of successful use of dental implants, the clinical factors to declare a successful osseointegrated implant have changed [<span>2-6</span>]. Oral rehabilitation using dental implants has become a treatment dependent on specialized professionals who target handling complex long-term cases combining surgical, periodontal, and prosthetic approaches, thinking beyond just implant insertion and early osseointegration. Currently, the concept of implant success and its long-term osseointegration reveals a progressive complexity involving short and long-term factors in implant dentistry. Biological, mechanical, functional, technological, genetic, prosthetic, esthetic, and health quality indicators (PROMs) can be cited as actual components to determine implant and osseointegration success [<span>2-6</span>]. Nevertheless, many of these factors may bring up miscellaneous opinions of what should be considered “implant success” or “osseointegration success” in the currently available knowledge, as well as, patients may show different feedback's about their satisfaction with implant treatments. Osseointegration success may be considered a stable implant in oral function with the absence of inflamed/contaminated surrounding tissues and peri-implant bone loss. However, nowadays, the term “implant success” has achieved priority and embraces much more than healthy surrounding tissues; esthetics, correct implant positioning, treatment durability, changes in quality of life, and patient-related outcomes are crucial in the contemporaneous definition [<span>6</span>]. The evaluation of solely peri-implant tissue status is insufficient to achieve the current clinical scientific evidence needed to report quality of care, patient satisfaction, and treatment success in implant dentistry [<span>6</span>]. These multiple factors highlight the need for optimal surgical planning and safety protocols in implantology aiming for long-term clinical durability. On the other hand, questionable treatments with dental implants and diverse clinical decisions may curren","PeriodicalId":16715,"journal":{"name":"Journal of periodontal research","volume":"60 9","pages":"854-857"},"PeriodicalIF":3.4,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jre.70009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144560359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pingping Han, Kexin Jiao, Peter Mark Bartold, Andrew Liaw, Wei Wei, Sašo Ivanovski
Salivary circular RNAs, particularly hsa_circ_0003563 (circRUNX2) and hsa_circ_0001161 (circMMP9), show strong potential as non-invasive biomarkers for diagnosing periodontitis and distinguishing the rate of disease progression, offering promising tools for improved periodontal diagnostics.